Trademark: 87650629
Word
ATARA
Status
Dead
Status Code
606
Status Date
Monday, December 3, 2018
Serial Number
87650629
Mark Type
4000
Filing Date
Wednesday, October 18, 2017
Published for Opposition
Tuesday, March 6, 2018
Abandoned Date
Monday, December 3, 2018
Trademark Owner History
Atara Biotherapeutics, Inc. - Owner At Publication
Classifications
5 house mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
Trademark Events
Dec 3, 2018
Abandonment Notice Mailed - No Use Statement Filed
Dec 3, 2018
Abandonment - No Use Statement Filed
May 1, 2018
Noa E-Mailed - Sou Required From Applicant
Mar 6, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 6, 2018
Published For Opposition
Feb 14, 2018
Notification Of Notice Of Publication E-Mailed
Jan 31, 2018
Approved For Pub - Principal Register
Jan 27, 2018
Assigned To Examiner
Oct 27, 2017
New Application Office Supplied Data Entered In Tram
Oct 21, 2017
New Application Entered In Tram
RHETT FOUNDATION FOR THE ADVANCEMENT OFPODIATRIC MEDICINE
HIGHLY SENSITIVE LEADER
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov